Consistent with previous reports, we found that mutations in CTNNB1 were frequently identified in HCC and MMs in CTNNB1 were also frequently found in 14% (11/79) of samples with at least one mutation. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.